Literature DB >> 15652666

DNA vaccination against respiratory syncytial virus in young calves.

Geraldine Taylor1, Catriona Bruce, Anthony F Barbet, Sara G Wyld, Lewis H Thomas.   

Abstract

A DNA vaccine encoding the fusion (F) gene (DNA-F) of bovine respiratory syncytial virus (BRSV) induced significant protection against BRSV infection in young calves. However, serum antibody to RSV developed more slowly in animals vaccinated with DNA-F when compared with those previously infected with BRSV. Furthermore, protection against BRSV infection was not as great as that induced by prior BRSV infection. Although there was little difference in the level of protection induced in calves vaccinated with DNA-F by either the intramuscular (i.m.) or intradermal (i.d.) routes, only the i.m. route primed for a rapid BRSV-specific IgA response after BRSV challenge. These results indicate that a DNA vaccination may be effective against RSV infection even in very young infants and calves.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15652666     DOI: 10.1016/j.vaccine.2004.09.005

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Induction of mucosal immunity through systemic immunization: Phantom or reality?

Authors:  Fei Su; Girishchandra B Patel; Songhua Hu; Wangxue Chen
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

2.  Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency.

Authors:  Mohamed A Farrag; Haitham M Amer; Peter Öhlschläger; Maaweya E Hamad; Fahad N Almajhdi
Journal:  Hum Vaccin Immunother       Date:  2017-03-08       Impact factor: 3.452

3.  DNA immunization with plasmids encoding fusion and nucleocapsid proteins of bovine respiratory syncytial virus induces a strong cell-mediated immunity and protects calves against challenge.

Authors:  Mathieu Boxus; Marylène Tignon; Stefan Roels; Jean-François Toussaint; Karl Walravens; Marie-Ange Benoit; Philippe Coppe; Jean-Jacques Letesson; Carine Letellier; Pierre Kerkhofs
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

Review 4.  DNA vaccines in veterinary use.

Authors:  Laurel Redding; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2009-09       Impact factor: 5.217

Review 5.  Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?

Authors:  Mattia Tiboni; Luca Casettari; Lisbeth Illum
Journal:  Int J Pharm       Date:  2021-05-06       Impact factor: 6.510

Review 6.  Animal models of respiratory syncytial virus infection.

Authors:  Geraldine Taylor
Journal:  Vaccine       Date:  2016-11-29       Impact factor: 3.641

7.  Similar Epitope Specificities of IgG and IgA Antibodies Elicited by Ad26 Vector Prime, Env Protein Boost Immunizations in Rhesus Monkeys.

Authors:  Zi Han Kang; Christine A Bricault; Erica N Borducchi; Kathryn E Stephenson; Michael S Seaman; Maria Pau; Hanneke Schuitemaker; Danielle van Manen; Frank Wegmann; Dan H Barouch
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

8.  A single vaccination with an inactivated bovine respiratory syncytial virus vaccine primes the cellular immune response in calves with maternal antibody.

Authors:  Mirjam T W van der Sluijs; Eva M Kuhn; Birgit Makoschey
Journal:  BMC Vet Res       Date:  2010-01-11       Impact factor: 2.741

9.  Characterization of an experimental vaccine for bovine respiratory syncytial virus.

Authors:  Sara Hägglund; Kefei Hu; Krister Blodörn; Boby Makabi-Panzu; Anne-Laure Gaillard; Karin Ellencrona; Didier Chevret; Lars Hellman; Karin Lövgren Bengtsson; Sabine Riffault; Geraldine Taylor; Jean François Valarcher; Jean-François Eléouët
Journal:  Clin Vaccine Immunol       Date:  2014-05-14

10.  Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies.

Authors:  Krister Blodörn; Sara Hägglund; Jenna Fix; Catherine Dubuquoy; Boby Makabi-Panzu; Michelle Thom; Per Karlsson; Jean-Louis Roque; Erika Karlstam; John Pringle; Jean-François Eléouët; Sabine Riffault; Geraldine Taylor; Jean François Valarcher
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.